AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2023
Aug 10, 2023
33899_dirs_2023-08-10_60b388b0-e96d-4696-bd8c-59b78513a0a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-08-08
Reporting Person: Hoer Michael A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Common Stock | P | 37.644 | $89.42 | Acquired | 8325.709 | Direct |
Footnotes
F1: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
More from MEDIFAST INC
Regulatory Filings
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 17